Clinical Trial Update: Evaluating Genetic Risk Factors for Childhood-Onset Schizophrenia

View source ↗

Summary

A National Institute of Mental Health-sponsored clinical trial evaluating genetic risk factors for childhood-onset schizophrenia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Childhood-onset Schizophrenia
• Psychosis
• Schizoaffective Disorder
• Schizophrenia

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: Psychosis, Schizophrenia | Status: TERMINATED